304 related articles for article (PubMed ID: 16972375)
21. Response to open peer commentaries on "The pitfalls of deducing ethics from economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing".
Huddle TS
Am J Bioeth; 2010 Jan; 10(1):W1-3. PubMed ID: 20077322
[No Abstract] [Full Text] [Related]
22. Small gifts, conflicts of interest, and the zero-tolerance threshold in medicine.
Krimsky S
Am J Bioeth; 2003; 3(3):50-2. PubMed ID: 14594492
[No Abstract] [Full Text] [Related]
23. The pitfalls of deducing ethics from behavioral economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing.
Huddle TS
Am J Bioeth; 2010 Jan; 10(1):1-8. PubMed ID: 20077321
[TBL] [Abstract][Full Text] [Related]
24. Gifts to physicians from the pharmaceutical industry: an ethical analysis.
Marco CA; Moskop JC; Solomon RC; Geiderman JM; Larkin GL
Ann Emerg Med; 2006 Nov; 48(5):513-21. PubMed ID: 17052550
[TBL] [Abstract][Full Text] [Related]
25. Doctors and drug companies.
Lambert LA
N Engl J Med; 2005 Feb; 352(7):733-4; author reply 733-4. PubMed ID: 15716575
[No Abstract] [Full Text] [Related]
26. Doctors and drug companies.
Blumenthal D
N Engl J Med; 2004 Oct; 351(18):1885-90. PubMed ID: 15509823
[No Abstract] [Full Text] [Related]
27. CME shelter. Sunshine Act waiver for med ed payments may prompt marketing shift for product makers.
Lee J
Mod Healthc; 2014 Jun; 44(26):16-9. PubMed ID: 25134407
[No Abstract] [Full Text] [Related]
28. The ethics of pharmaceutical industry gift-giving: the role of a professional association.
Morin K; Morse LJ
Am J Bioeth; 2003; 3(3):54-5. PubMed ID: 14594494
[No Abstract] [Full Text] [Related]
29. Inducements by Pharmaceutical Companies: The Elephant in the Room.
Soans ST
Indian Pediatr; 2018 Aug; 55(8):649-651. PubMed ID: 30218507
[No Abstract] [Full Text] [Related]
30. Drug makers pay for lunch as they pitch.
Saul S
N Y Times Web; 2006 Jul; ():A1, C7. PubMed ID: 16909492
[No Abstract] [Full Text] [Related]
31. Medical students protest perks from drug companies.
Opar A
Nat Med; 2006 Oct; 12(10):1104. PubMed ID: 17024192
[No Abstract] [Full Text] [Related]
32. All rationalizations large and small.
Goodman B
Am J Bioeth; 2003; 3(3):57-8. PubMed ID: 14594496
[No Abstract] [Full Text] [Related]
33. Who rules the great Indian drug bazaar?
Roy N
Indian J Med Ethics; 2004; 1(1):2-3. PubMed ID: 16370060
[No Abstract] [Full Text] [Related]
34. All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving.
Katz D; Caplan AL; Merz JF
Am J Bioeth; 2010 Oct; 10(10):11-7. PubMed ID: 20945262
[TBL] [Abstract][Full Text] [Related]
35. Should a medical practice accept a gift with strings attached?
Agrawal M; Steinberg D
Med Ethics (Burlingt Mass); 2001; ():3, 7. PubMed ID: 15584189
[No Abstract] [Full Text] [Related]
36. Gifts to physicians from industry: the debate evolves.
Moskop JC; Iserson KV; Aswegan AL; Larkin GL; Schears RM
Ann Emerg Med; 2012 Feb; 59(2):89-97. PubMed ID: 21875761
[TBL] [Abstract][Full Text] [Related]
37. The physician and the pharmaceutical industry: both must keep the patient's interests at heart.
Ravindran GD
Issues Med Ethics; 1999; 7(1):21-2. PubMed ID: 16320467
[No Abstract] [Full Text] [Related]
38. New developments in managing physician-industry relationships.
Rothman DJ; Chimonas S
JAMA; 2008 Sep; 300(9):1067-9. PubMed ID: 18768417
[No Abstract] [Full Text] [Related]
39. A quiz on "the ethics of accepting gifts from industry".
Holm RP;
S D Med; 2007 Mar; 60(3):117-8. PubMed ID: 17455581
[TBL] [Abstract][Full Text] [Related]
40. Drug detailing in academic medical centers: regulating for the right reasons, with the right evidence, at the right time.
Steinman MA; Schillinger D
Am J Bioeth; 2010 Jan; 10(1):21-3. PubMed ID: 20077331
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
